Renaissance Technologies - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 37 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$286
-53.5%
129,524
-46.5%
0.00%
-100.0%
Q1 2023$615
+35.2%
242,124
-0.6%
0.00%0.0%
Q4 2022$455
-99.9%
243,524
+6.4%
0.00%0.0%
Q3 2022$588,000
+2.6%
228,824
-22.9%
0.00%0.0%
Q2 2022$573,000
+11.3%
296,676
+71.1%
0.00%0.0%
Q1 2022$515,000
+197.7%
173,424
+349.0%
0.00%
Q4 2021$173,000
-82.3%
38,624
-80.8%
0.00%
-100.0%
Q3 2021$980,000
-66.5%
201,624
-52.9%
0.00%
-75.0%
Q2 2021$2,922,000
-31.5%
428,424
-29.0%
0.00%
-20.0%
Q1 2021$4,263,000
-10.5%
603,820
-20.7%
0.01%0.0%
Q4 2020$4,765,000
+62.7%
761,220
+40.6%
0.01%
+66.7%
Q3 2020$2,929,000
+19.3%
541,420
+15.1%
0.00%
+50.0%
Q2 2020$2,456,000
+392.2%
470,508
+276.0%
0.00%
Q2 2019$499,000
-67.7%
125,149
-56.5%
0.00%
-100.0%
Q1 2019$1,543,000
-13.1%
287,849
-16.8%
0.00%
-50.0%
Q4 2018$1,776,000
-15.5%
346,170
+59.6%
0.00%0.0%
Q3 2018$2,103,000
-83.7%
216,849
-80.5%
0.00%
-71.4%
Q2 2018$12,928,000
+74.2%
1,110,798
+94.6%
0.01%
-12.5%
Q1 2018$7,421,000
-8.0%
570,849
+26.7%
0.01%
-11.1%
Q4 2017$8,067,000
-13.3%
450,649
+21.6%
0.01%
-18.2%
Q3 2017$9,306,000
-35.3%
370,738
-37.9%
0.01%
-38.9%
Q2 2017$14,382,000
+80.2%
596,749
+44.0%
0.02%
+63.6%
Q1 2017$7,979,000
+369.9%
414,513
+275.9%
0.01%
+266.7%
Q4 2016$1,698,000
-9.1%
110,264
-23.2%
0.00%0.0%
Q3 2016$1,867,000
+31.3%
143,513
+40.3%
0.00%0.0%
Q2 2016$1,422,000
+19.3%
102,264
+30.2%
0.00%
+50.0%
Q1 2016$1,192,000
-25.0%
78,564
-6.3%
0.00%
-33.3%
Q4 2015$1,590,000
-15.3%
83,813
-15.2%
0.00%
-25.0%
Q3 2015$1,877,000
-30.0%
98,813
-5.1%
0.00%
-33.3%
Q2 2015$2,682,000
+117.3%
104,086
+163.7%
0.01%
+100.0%
Q1 2015$1,234,000
+37.0%
39,464
+68.9%
0.00%
+50.0%
Q4 2014$901,00023,3640.00%
Other shareholders

There were no reported owners of PARATEK PHARMACEUTICALS INC in Q4 2014.

NameSharesValueWeighting ↓
View complete list of PARATEK PHARMACEUTICALS INC shareholders